USPTO Leaders Reinstate Double Patenting Ax In Sanofi Case
A panel including U.S. Patent and Trademark Office Director John Squires ruled Thursday that a Sanofi patent application must be rejected for double patenting, but questioned whether the rationale for the...To view the full article, register now.
Already a subscriber? Click here to view full article